Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to evaluate the image quality for different iodine delivery rates at different low voltage scanning protocols (80 or 100 kV ) under the modern advanced Multi-Detector Computed Tomography (MDCT) considering the body weight of patients.
The purpose of this study is to evaluate the image quality of different acquisition protocols in patients weighing less than 90 kg using low voltage 80 or 100 kV with a lower Iodine Delivery Rate based on the body weight of the patient, who will undertake coronary or craniocervical CTA (Computed Tomography Angiography) in routine procedures.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Setting 1 of Iopromide | Craniocervical CTA under below setting: injection rate of iopromide: 4 ml/s, concentration of iopromide = 300 mgI/ml, injection dose of iopromide: 0.8 ml/kg BW, tube voltage = 80 kvp |
| |
| Setting 2 of Iopromide | Craniocervical CTA under below setting: injection rate of iopromide: 3.2 ml/s, concentration of iopromide = 370 mgI/ml, injection dose of iopromide: 0.65 ml/kg BW, tube voltage = 80 kvp |
| |
| Setting 3 of Iopromide | Craniocervical CTA under below setting: injection rate of iopromide: 3.2 ml/s, concentration of iopromide = 300 mgI/ml, injection dose of iopromide: 0.8 ml/kg BW, tube voltage = 80 kvp |
| |
| Setting 4 of Iopromide | Craniocervical CTA under below setting: injection rate of iopromide: 4 ml/s, concentration of iopromide = 370 mgI/ml, injection dose of iopromide: 0.8 ml/kg BW, tube voltage = 100 kvp |
| |
| Setting 5 of Iopromide | Coronary CTA under below setting: injection rate of iopromide: 4 ml/s, concentration of iopromide = 300 mgI/ml, injection dose of iopromide: 0.8 ml/kg BW, tube voltage = 80 kvp |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Iopromide (Ultravist, BAY86-4877) | Drug | 8 settings for CT Angiography as described in group description. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Contrast opacification of the target vascular segments, measured in Hounsfield Units (HU) | Defined as the CT value which can be measured on the CTA images. | Up to 1 week |
| Measure | Description | Time Frame |
|---|---|---|
| Value of CNR (contrast-noise ratio) of the vascular segments | Calculated by the formula: CNR = [Averaged vascular segmental CT value - brain parenchyma (for carniocervical CTA) / perivascular tissues (for Coronary CTA (CCTA)) CT value] / image noise | Up to 1 week |
| Value of SNR (signal-noise ratio) of the vascular segments |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients referred for CT Angiography for examination of the cerebral arteries (suspicion of cerebral artery stenosis or embolism, or suspected carotid pathology) or for examination of the coronary arteries receiving Ultravist at 80 or 100 kV can be enrolled in this study.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bayer Study Director | Bayer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Multiple Locations | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35103828 | Derived | Wang Y, Chen Y, Liu P, Lv W, Wu J, Wei M, Shi D, Wu X, Liu W, Tao X, Hu H, Ma X, Yang X, Xue H, Jin Z. Clinical effectiveness of contrast medium injection protocols for 80-kV coronary and craniocervical CT angiography-a prospective multicenter observational study. Eur Radiol. 2022 Jun;32(6):3808-3818. doi: 10.1007/s00330-021-08505-5. Epub 2022 Feb 1. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Setting 6 of Iopromide | Coronary CTA under below setting: injection rate of iopromide: 3.2 ml/s, concentration of iopromide = 370 mgI/ml, injection dose of iopromide: 0.65 ml/kg BW, tube voltage = 80 kvp |
|
| Setting 7 of Iopromide | Coronary CTA under below setting: injection rate of iopromide: 3.2 ml/s, concentration of iopromide = 300 mgI/ml, injection dose of iopromide: 0.8 ml/kg BW, tube voltage = 80 kvp |
|
| Setting 8 of Iopromide | Coronary CTA under below setting: injection rate of iopromide: 4 ml/s, concentration of iopromide = 370 mgI/ml, injection dose of iopromide: 0.8 ml/kg BW, tube voltage = 100 kvp |
|
Calculated by the formula: SNR = Averaged vascular segmental CT value / image noise |
| Up to 1 week |
| Score of visual assessment of the CTA image quality | Subjective visual assessment using a 4-point scale:
| Up to 1 week |
| Score of diagnostic confidence of the CTA images | Subjective assessment of diagnostic confidence in the delineation of pathologic findings using a 4-point scale:
| Up to 1 week |
| Injected dosage (ml) of the contrast media (CM) | Can be read from the screen of the CT injector. | Up to 24 hours |
| Injection rate (ml/s) of the contrast media | Can be read from the screen of the CT injector. | Up to 24 hours |
| Value of the Idoine delivery rate (IDR) (unit: mg I/s) | Calculated by the formula: IDR (mg I/s) = CM concentration (mg I/ml) * CM injection rate (ml/s) | Up to 1 week |
| Value of the volume CT dose index (CTDIvol) (unit: mGy) | A parameter of the radiation dose which can be automatically generated and recorded by the CT machine. | Up to 1 week |
| Value of the dose length product (DLP) (unit: mGy*cm) | A parameter of the radiation dose which can be automatically generated and recorded by the CT machine. | Up to 1 week |
| Value of the effective dose (organ dose) (unit: mSv) | The effective radiation dose which can be estimated by DLP multiplied by a specific conversion coefficient. | Up to 1 week |
| Heart rate of the patients who underwent CCTA before and after the CM injection | It can be read from the screen of the ECG monitor of the CT machine | Up to 24 hours |
| Presence of injection pain or discomfort of the patients (Yes/No) | Assessed by investigators by asking patients if they have injection pain or discomfort. | Up to 24 hours |
| Number of patients with adverse events / adverse drug reactions | Up to 1 hour |
| Severity of injection pain or discomfort of the patients | Assessed by investigators by asking the patients of the severity (mild, moderate, severe) if present. | Up to 24 hours |
| ID | Term |
|---|---|
| C038192 | iopromide |
Not provided
Not provided
Not provided